Hadeel Delman Najim et al. 2024. Influence of Adding Empagliflozin to Conventional Anti-diabetic Therapy on Quality of Life Scale for Type 2 Diabetic Patients. Iraqi Journal of Pharmaceutical Sciences. 33, 3 (Sep. 2024), 142–149. DOI:https://doi.org/10.31351/vol33iss3pp142-149.